Article Data

  • Views 464
  • Dowloads 158

Original Research

Open Access

Clinical characteristics, management, and treatment outcomes of epididymo-orchitis among patients in a referral hospital in Southern Saudi Arabia

  • Abdullah Ayed1,†
  • Raed Alwadai2
  • Shahzada K. Sohail3
  • Syeda F. Rizvi3
  • Najim Z. Alshahrani4
  • Omar B. Ahmed5
  • Mutasim E. Ibrahim6,*,†,

1Department of Surgery, College of Medicine, University of Bisha, 67614 Bisha, Saudi Arabia

2Department of Urology, King Abdullah Hospital, Ministry of Health, 67714 Bisha, Saudi Arabia

3Department of Pathology, College of Medicine, University of Bisha, 67614 Bisha, Saudi Arabia

4Department of Family and Community Medicine, Faculty of Medicine, University of Jeddah, 21589 Jeddah, Saudi Arabia

5Department of Environmental and Health Research, The Custodian of the Two Holy Mosques Institute for Hajj and Umrah Research, Umm Al-Qura University, 21955 Makkah, Saudi Arabia

6Department of Microbiology and Clinical Parasitology, College of Medicine, University of Bisha, 67614 Bisha, Saudi Arabia

DOI: 10.22514/jomh.2024.066 Vol.20,Issue 5,May 2024 pp.21-29

Submitted: 19 December 2023 Accepted: 05 January 2024

Published: 30 May 2024

*Corresponding Author(s): Mutasim E. Ibrahim E-mail: meibrahim@ub.edu.sa

† These authors contributed equally.

Abstract

Epididymo-orchitis (EO) is a common genitourinary clinical syndrome in men, and delayed investigation and improper management can lead to complications. This study aimed to analyze clinical and laboratory findings and treatment outcomes in EO patients. We conducted a retrospective record-based study at King Abdullah Hospital in southern Saudi Arabia from 2018 to 2022, reviewing data from 63 EO patients who had a median age of 34 years (range: 16–82 years). The results showed that the most common complaints were scrotal pain and swelling (54%), followed by testicular pain (44.4%). Scrotal ultrasonography showed increased vascularity in both testes and epididymis in 49 patients (77.8%), while 14 patients (22.2%) had epididymal involvement alone. Reactive hydrocele was observed in 15 patients (23.8%), abscesses in seven (11.1%), and hypoechoic lesions in three (3.8%). Anti-Brucella antibody titers (≥1:80) were detected in 22 cases, and 14.3% had positive urine cultures. Of the patients, 87.3%responded well to the initial treatment course, while four (6.3%) were cured after a second course of treatment. EO complications occurred in three cases (4.8%), and one patient (1.6%) succumbed to septicemia. Of the 15 patients treated with ceftriaxone and ciprofloxacin, one required orchiectomy due to non-response. Relapse occurred in one of the 10 patients treated with triple therapy (doxycycline, rifampicin and gentamicin). Among the nine patients treated with ceftriaxone and co-trimoxazole, one did not respond, developed a testicular abscess, and underwent incision and drainage. In conclusion, our study highlights that most cases of EO can be effectively resolved with appropriate antibiotic therapy, particularly combinations containing cefuroxime and/or ciprofloxacin. Clinicians in Brucella-endemic regions should consider the possibility of brucellosis as an underlying cause of EO.


Keywords

Epididymo-orchitis; Management; Treatment outcomes; Complication; Saudi Arabia


Cite and Share

Abdullah Ayed,Raed Alwadai,Shahzada K. Sohail,Syeda F. Rizvi,Najim Z. Alshahrani,Omar B. Ahmed,Mutasim E. Ibrahim. Clinical characteristics, management, and treatment outcomes of epididymo-orchitis among patients in a referral hospital in Southern Saudi Arabia. Journal of Men's Health. 2024. 20(5);21-29.

References

[1] Bonner M, Sheele JM, Cantillo-Campos S, Elkins JM. A descriptive analysis of men diagnosed with epididymitis, orchitis, or both in the emergency department. Cureus. 2021; 94: e15800.

[2] Khodadadi J, Dodangeh M, Nasiri M. Brucellar epididymo-orchitis: Symptoms, diagnosis, treatment and follow-up of 50 patients in Iran. IDCases. 2023; 32: e01736.

[3] Celik M, Akgul F, Alkan S, Altindag D, Esmer F, Sahin A, et al. Testicular involvement of brucellosis: a 10-year, multicenter study. The Journal of Infection in Developing Countries. 2023; 17: 1285–1291.

[4] Street EJ, Justice ED, Kopa Z, Portman MD, Ross JD, Skerlev M, et al. The 2016 European guideline on the management of epididymo-orchitis. International Journal of STD & AIDS. 2017; 28: 744–749.

[5] Ryan L, Daly P, Cullen I, Doyle M. Epididymo-orchitis caused by enteric organisms in men >35 years old: beyond fluoroquinolones. European Journal of Clinical Microbiology & Infectious Diseases. 2018; 37: 1001–1008.

[6] Nicholson A, Rait G, Murray-Thomas T, Hughes G, Mercer CH, Cassell J. Management of epididymo-orchitis in primary care: results from a large UK primary care database. British Journal of General Practice. 2010; 60: e407–e422.

[7] Gozdas HT, Bal T. Brucellar epididymo-orchitis: a retrospective study of 25 cases. The Aging Male. 2020; 23: 29–32.

[8] Al-Tawfiq JA, AbuKhamsin A. A 24-year study of the epidemiology of human brucellosis in a health-care system in Eastern Saudi Arabia. Journal of Infection and Public Health. 2009; 2: 81–85.

[9] Alaidarous M. Prevalence of brucellosis in Hawtat Sudair city, Riyadh province, Saudi Arabia. Majmaah Journal of Health Sciences. 2018; 7: 17–25.

[10] Al Anazi M, AlFayyad I, AlOtaibi R, Abu-Shaheen A. Epidemiology of brucellosis in Saudi Arabia. Saudi Medical Journal. 2019; 40: 981–988.

[11] Alsubaie SA, Turkistani SA, Zeaiter AA, Thabit AK. Lack of correlation of brucella antibody titers with clinical outcomes and culture positivity of brucellosis. Tropical Diseases, Travel Medicine and Vaccines. 2021; 7: 5.

[12] Edathodu J, Alamri M, Alshangiti KA, Alfagyh NS, Alnaghmush AS, Albaiz F, et al. Clinical manifestations and treatment outcomes of human brucellosis at a tertiary care center in Saudi Arabia. Annals of Saudi Medicine. 2021; 41: 109–114.

[13] Al-Faifi J, Ibrahim ME. Congenital brucellosis associated with subsequent Klebsiella pneumoniae co-infection in a premature neonate: a rare case report. Journal of Infection and Public Health. 2022; 15: 586–588.

[14] Ibrahim ME, Al-Shahrani MS. The incidence and clinical manifestations of human brucellosis in a referral hospital in Southern Saudi Arabia between 2015 and 2019. Acta Microbiologica et Immunologica Hungarica. 2021; 68: 128–134.

[15] Alkahtani AM, Assiry MM, Chandramoorthy HC, Al-Hakami AM, Hamid ME. Sero-prevalence and risk factors of brucellosis among suspected febrile patients attending a referral hospital in southern Saudi Arabia (2014–2018). BMC Infectious Diseases. 2020; 20: 26.

[16] Kanjo MA, Ahmed HM, Alnahari EA. Unusual presentation of neurobrucellosis in Jeddah, Kingdom of Saudi Arabia. Neurosciences. 2021; 26: 385–388.

[17] Hamoda TAA, Bahassan O, Almalki AM, Alkhzaim AH, Khogeer AN, Ahmed EM, et al. Brucellar testicular abscess: the 17th case report and review of literature. Urology Annals. 2023; 15: 340–348.

[18] Memish ZA, Venkatesh S. Brucellar epididymo-orchitis in Saudi Arabia: a retrospective study of 26 cases and review of the literature. BJU International. 2001; 88: 72–76.

[19] Nahas RS, Alsulami A, Lashkar MO, Thabit AK. Brucella epidydimo-orchitis successfully treated with dual oral drug regimen: a case report with differential diagnoses of malignancy and tuberculosis. Radiology Case Reports. 2022; 17: 3485–3489.

[20] Sieger N, Di Quilio F, Stolzenburg J. What is beyond testicular torsion and epididymitis? Rare differential diagnoses of acute scrotal pain in adults: a systematic review. Annals of Medicine and Surgery. 2020; 55: 265–274.

[21] Alsubaie S, Almuneef M, Alshaalan M, Balkhy H, Albanyan E, Alola S, et al. Acute brucellosis in Saudi families: relationship between brucella serology and clinical symptoms. International Journal of Infectious Diseases. 2005; 9: 218–224.

[22] Cift A, Yucel MO. Comparison of inflammatory markers between brucella and non-brucella epididymo-orchitis. International Brazilian Journal of Urology. 2018; 44: 771–778.

[23] Çalışma BER. Brucellar Epididymo-orchitis: a retrospective study. Trakya Üniversitesi Tip Fakültesi Dergisi. 2009; 26: 220–225.

[24] Jin M, Fan Z, Gao R, Li X, Gao Z, Wang Z. Research progress on complications of brucellosis. Frontiers in Cellular and Infection Microbiology. 2023; 13: 1136674.

[25] Salem S, Alarbid A, Alenezi T, Alenezzi A, Alali K, Ajrawi F, et al. Early predictors of brucella epididymo-orchitis. Urology Annals. 2023; 15: 158–161.

[26] Korkmaz N, Ölçücü MT, Ateş F. Comparision of brucella and non-brucella epididymo-orchitis. Journal of College of Physicians and Surgeons Pakistan. 2020; 30: 403–406.

[27] Ye H, Xing F, Yang J, Lo SK, Lau RW, Chen JH, et al. High index of suspicion for brucellosis in a highly cosmopolitan city in southern China. BMC Infectious Diseases. 2020; 20: 22.

[28] Alshubaili HM, Alharbi KI, Elsirafy MN, Abuanz SM, Hasan RM. Acute right epididymo-orchitis complicated by pampiniform plexus thrombosis. Urology Case Reports. 2020; 31: 101171.

[29] Abolghasemi S, Alizadeh M, Hashemi A, Tehrani S. Etiology and clinical features of epididymo-orchitis: a single-center study in Tehran, Iran. Infectious Disorders - Drug Targets. 2021; 21: 142–145.

[30] Tan J, Tian M, Zhao F, Deng S, Jin P, Wang Y, et al. An investigation of the male genitourinary abscess originated from urinary tract in a tertiary hospital, Shanghai, China, from 2004 to 2019. Infection and Drug Resistance. 2021; 14: 1795–1803.

[31] Navarro-Martiínez A, Solera J, Corredoira J, Beato JL, Martínez-Alfaro EM, Atieénzar M, et al. Epididymo-orchitis due to Brucella mellitensis: a retrospective study of 59 patients. Clinical Infectious Diseases. 2001; 33: 2017–2022.

[32] Huang Y, Chen B, Cao D, Chen Z, Li J, Guo J, et al. Surgical management of tuberculous epididymo-orchitis: a retrospective study of 81 cases with long-term follow-up. BMC Infectious Diseases. 2021; 21: 1068.

[33] Zehri AA, Ismail A, Adebayo P, Ali A. Testicular torsion induced by epididymo-orchitis: a case report. International Journal of Surgery Case Reports. 2021; 83: 106038.

[34] Gul HC, Akyol I, Sen B, Adayener C, Haholu A. Epididymoorchitis due to brucella melitensis: review of 19 patients. Urologia Internationalis. 2009; 82: 158–161.

[35] Roushan MR, Baiani M, Javanian M, Kasaeian AA. Brucellar epididymo-orchitis: review of 53 cases in Babol, northern Iran. Scandinavian Journal of Infectious Diseases. 2009; 41: 440–444.

[36] Coccolini F, Sartelli M, Sawyer R, Rasa K, Viaggi B, Abu-Zidan F, et al. Source control in emergency general surgery: WSES, GAIS, SIS-E, SIS-A guidelines. World journal of emergency surgery. 2023; 18: 41.

[37] Ibrahim ME. High antimicrobial resistant rates among Gram-negative pathogens in intensive care units. Saudi Medical Journal. 2018; 39: 1035–1043.

[38] Ibrahim ME, Algak TB, Abbas M, Elamin BK. Emergence of blaTEM, blaCTX-M, blaSHV, and blaOXA genes in multidrug-resistant Enterobacteriaceae and Acinetobacter baumannii in Saudi Arabia. Experimental and Therapeutic Medicine. 2021; 22: 1450.

[39] Alshahrani AM, Ibrahim ME, Aldossary AK, Alghamdi MA, Ahmed OB, Bin Abdulhak AA. Molecular epidemiology of carbapenem-resistant K. pneumoniae clinical isolates from the adult patients with comorbidities in a tertiary hospital, Southern Saudi Arabia. Antibiotics. 2022; 11: 1697.

[40] Ibrahim ME. Risk factors in acquiring multidrug-resistant Klebsiella pneumoniae infections in a hospital setting in Saudi Arabia. Scientific Reports. 2023; 13: 11626.

[41] Tufa TB, Mackenzie CR, Orth HM, Wienemann T, Nordmann T, Abdissa S, et al. Prevalence and characterization of antimicrobial resistance among gram-negative bacteria isolated from febrile hospitalized patients in central Ethiopia. Antimicrobial Resistance & Infection Control. 2022; 11: 8.

[42] Mukherjee S, Mitra S, Dutta S, Basu S. Neonatal sepsis: the impact of carbapenem-resistant and hypervirulent Klebsiella pneumoniae. Frontiers in Medicine. 2021; 8: 634349.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.

SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)

Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.

Scopus: CiteScore 0.9 (2023) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (https://kanalregister.hkdir.no/publiseringskanaler/Forside).

Submission Turnaround Time

Conferences

Top